Skip to product information
NaN of -Infinity

Berlin-Chemie AG

Flavamed Cough Tablets N20 bronchial disease, pulmonary

Flavamed Cough Tablets N20 bronchial disease, pulmonary

(0)
Regular price £38.99 GBP
Regular price £50.00 GBP Sale price £38.99 GBP
Sale Sold out
Tax included. Shipping calculated at checkout.

Flavamed Cough Tablets N20 bronchial disease, pulmonary


Flavamed Cough Tablets N20




PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USERS

Flavamed 30 mg tablets



Flavamed Cough Tablets bronchial disease, pulmonary Ambroxoli hydrochloridum



The leaflet should be read carefully because it contains information important for

the patient.

The drug is available over the counter, to enable the patients to treat some diseases

without consulting a doctor.


However, Flavamed should be used with caution to obtain a good result.


- The leaflet should be kept to be read again if necessary.

- A doctor or a pharmacist should be consulted if advice or additional information is

required.

- If the symptoms aggravate or fail to subside after 4 to 5 days, a doctor should be

consulted.

- If any adverse effect aggravates, or adverse effects not mentioned in the leaflet occur, a

doctor or a pharmacist should be consulted.



Flavamed Cough Tablets bronchial disease, pulmonary:




1. What is Flavamed and what it is used for

2. Information important before Flavamed is taken

3. How Flavamed should be used

4. Potential adverse effects

5. How Flavamed should be stored

6. Other information


Flavamed Cough Tablets N20 bronchial disease, pulmonary:




1. WHAT IS FLAVAMED AND WHAT IT IS USED FOR

Flavamed is a mucolytic agent used in respiratory tract disorders.

Flavamed is used in pulmonary and bronchial diseases associated with production of thick

mucus. Owing to the effect of Flavamed, thick mucus becomes more liquid and easier to

expectorate.

2. INFORMATION IMPORTANT BEFORE FLAVAMED IS TAKEN

Flavamed should not be used in the following cases

- if the patient is found to be allergic (hypersensitive to the active substance of Flavamed

(ambroxol hydrochloride) or any of the other components of the drug, see section 6 „What

Flavamed contains”).

- in children below 6 years of age.

Flavamed should be used with particular caution

- if the patient had in the past severe allergic skin reactions (Stevens-Johnson syndrome,

Lyell syndrome).

• Stevens-Johnson syndrome is a condition characterized by high fever and vesicular skin

eruptions on the skin and mucous membranes.

• life-threatening Lyell syndrom is also known as burnt skin syndrome.

The symptoms include severe skin lesions in the form of vesicles similar to those observed in

scalds and burns.

Flavamed Cough Tablets N20 bronchial disease, pulmonary:



Therefore, if the patient develops any lesions on the skin or mucous membranes, Flavamed

should be discontinued immediately. A physician should be consulted!

- if the patient has impaired renal function or a severe liver disease. In such cases, Flavamed

should be used with particular caution (i.e. longer intervals between the consecutive doses or

lower doses of the drug – a physician should be consulted). In severe renal failure the

metabolites of Flavamed may ccumulate in the organism.

- if the patient suffers from a bronchial condition associated with increased mucus production

(e.g. ciliary immobility syndrome). In such a case, the mucus cannot be removed from the

lungs. Flavamed should be used only under the supervision of a doctor.

- in patients with a history of gastric and/or duodenal ulcers, a physician should be consulted

how to use Flavamed, because mucolytic agents can damage the gastric mucosa. Before

the use of Flavame a doctor must be consulted.

Children

Flavamed can be used only in children above 6 years of age.

Co-administration of Flavamed with other drugs

The doctor should be informed about all current and recent medications, also those available

over the counter.


Flavamed Cough Tablets N20 bronchial disease, pulmonary:



Cough inhibitors

No drugs inhibiting the cough reflex (so-called cough inhibitors) should be used during the

treatment with Flavamed. The cough reflex is important for elimination of liquefied mucus and

its removal from the lungs.

Pregnancy and lactation

Before the use of any drug a physician or a pharmacist should be consulted.

During pregnancy and breastfeeding, Flavamed can be used only if prescribed by a doctor!

There are no available data concerning the use of the drug during pregnancy and

breastfeeding. However, animal tests indicate that the active substance is excreted with milk.

Driving and machine operation

Flavamed exerts no effect, or insignificant effect, on the ability to drive and to operate

mechanical devices.

Important information concerning some components of Flavamed

The drug contains lactose (a saccharide occurring in milk). If the patient has been diagnosed

with intolerance of some saccharides, a doctor should be consulted before the drug is used.

3. HOW FLAVAMED SHOULD BE USED

Flavamed should always be used according to the instructions provided in the patient

information leaflet. In case of any doubts, a physician or a pharmacist should be consulted.

The information provided below is applicable if the doctor recommends no other dosage. The

instructions should be followed because otherwise Flavamed will not act correctly.


Flavamed Cough Tablets N20 bronchial disease, pulmonary.

If not indicated otherwise by the doctor, the usual doses are as follows:



Age Single dose Maximum daily dose

Children aged 6 - 12

years

½ tablet 2 to 3 times daily

(corresponding to 15 mg of

ambroxol hydrochloride 2 – 3

times daily).

1½ tablets

(corresponding to 45 mg

of ambroxol

hydrochloride).

Adults and

adolescents above 12

years of age

During the first 2 – 3 days, 1

tablet 3 times daily

(corresponding to 30 mg of

ambroxol hydrochloride 3 times

daily);

then 1 tablet of the drug twice

daily (corresponding to 30 mg of

ambroxol hydrochloride twice

daily).

3 tablets (corresponding

to 90 mg of ambroxol

hydrochloride).

Note:

In adults the dose can be increased to 2 tablets twice a day.

Administration

Flavamed tablets should preferably be swallowed whole, followed by an appropriate amount

of liquid (e.g. water, tea or fruit juice).

The tablet can be divided into two halves.

Duration of treatment

If no physician has been consulted, Flavamed should not be taken longer than 4 – 5 days.

If after 4 – 5 days the symptoms fail to subside, or even aggravate, a doctor should be

consulted immediately!

In case of an impression that the effect of Flavamed is too potent or too weak, a physician or

a pharmacist should be consulted.

Overdose of Flavamed

No severe poisoning symptoms have been observed. Transient agitation and diarrhea may

occur.

In case of significant overdose, increased salivation may occur, as well as nausea, vomiting

and hypotension. A doctor should be consulted. Usually immediate intervention such as

induction of vomiting and gastric lavage is unnecessary; such management can be

considered in case of acute overdose. Treatment dependent on the observed symptoms of

overdose is recommended.

Missing a dose of Flavamed

In case of a missed dose, or too low dose of the drug taken, the next prescribed dose should

be taken at the usual time. No double dose to compensate for the missed one should be

used.

In case of any doubts associated with dosage of the drug, a physician or a pharmacist should

be consulted.

4. POTENTIAL ADVERSE EFFECTS

Like any other drug, Flavamed may cause adverse effects, although they are not observed in

all patients.

Adverse effects are assessed according to the following frequency criteria:

Very frequent In more than 1 out of 10 treated patients

Frequent

In fewer than 1 out of 10, but more than 1 out of 100 treated

patients

Infrequent

In fewer than 1 out of 100, but more than 1 out of 1 000 treated

patients

Rare.

In fewer than 1 out of 1 000, but more than 1 out of 10 000

treated patients

Very rare

In fewer than 1 out of 10 000 treated patients

Unknown (the frequency cannot be estimated on the basis of

available data).

Adverse effects

Gastrointestinal:

Infrequent: Stomachache, nausea, vomiting

Skin and subcutaneous tissue:

Very rare: Severe dermal reactions, such as Lyell syndrome and Stevens-Johnson syndrome

(see section 2 „When Flavamed should be used with particular caution”)

Systemic disorders and local conditions:

Infrequent: Hypersensitivity reactions such as rash, facial edema, respiratory disturbances,

pruritus, fever

Very rare: Severe allergic reactions (anaphylaxia), including anaphylactic shock

Management.

In case of one or more of the aforementioned adverse effects, treatment with Flavamed

should be discontinued.

If any adverse effect aggravates, or adverse effects not mentioned in the leaflet occur, a

doctor or a pharmacist should be consulted.

5. HOW FLAVAMED SHOULD BE STORED

The drug should be stored out of the reach and sight of children.

Flavamed should not be used after the expiry date indicated on the blister and cardboard box

after the abbreviation EXP. The expiry date is the last day of the given month.

The drug should not be stored at temperatures exceeding 25°C.

The drug should not be disposed of in the sewage system or home waste bins. A pharmacist

should be consulted what to do with unwanted drugs. Such disposal method will help to

protect the environment.

6. OTHER INFORMATION

What Flavamed contains:

The active substance – ambroxol hydrochloride.

One tablet contains 30 mg of ambroxol hydrochloride. Other components of the drug include:

lactose monohydrate, corn starch, cellulose (powder), sodium croscaramellose, povidon K 30,

magnesium stearate.

Appearance of the drug and package content

White, round tablets, flat on both sides, with beveled edges and a division groove on one

side.

Flavamed is available in packages containing 10, 20 and 50 tablets.

Flavamed Cough Tablets bronchial disease, pulmonary 
Responsible entity and manufacturer:

Berlin-Chemie AG

Glienicker Weg 125

12489 Berlin, Germany


Flavamed Cough Tablets N20 bronchial disease, pulmonary

View full details